Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumour cells by stimulating the host anti-tumour immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma.

Request a free sample of our report on Oncolytic Virus Therapy Market: https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market

Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialised, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer. Melanoma is one of the cancers that has been prevalent across the US region. The first oncolytic virus success over chemotherapy and radiotherapy have paved ways for developing them for other cancers. The other factors are the side effects associated with conventional cancer therapies. Chemotherapy and radiation therapy cause certain side-effects such as prolonged exposure to radiation may cause skin cancer.

A full report of Oncolytic Virus Therapy Market Is available at https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market

Oncolytic Virus Therapy Market Segmentation

By Product

HSV-Based Oncolytic Viruses

Adenoviruses-Based Oncolytic Viruses

Vaccinia Virus-Based Oncolytic Viruses

Vesicular Stomatitis Virus-Based Oncolytic Viruses

Newcastle Disease Virus-Based Oncolytic Viruses

By Application

Prostate Cancer

Breast Cancer

Ovarian Cancer

Others

Competitive Landscape

Regional Analysis

North American

United States

Canada

Europe

UK

Germany

Italy

Spain

France

ROE

Asia Pacific

India

China

Japan

ROAPAC

Rest of the World

Company Profiles

Amgen

BioVex Inc.,

Cold Genesys, Inc.

Crusade Laboratories

Cynvec LLC

Genelux Corp.

JennerRex Co. Ltd

Lokon Pharma AB

MediGene AG

Merck

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/oncolytic-virus-therapy-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.



For More Information, Visit https://www.omrglobal.com/



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404